{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:38:01Z","timestamp":1791974281334,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009877","name":"Calabria Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PRIN 2022 - 2022XXX2XC"],"award-info":[{"award-number":["PRIN 2022 - 2022XXX2XC"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022 - 2022XXX2XC"],"award-info":[{"award-number":["PRIN 2022 - 2022XXX2XC"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118375","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T06:38:25Z","timestamp":1753079905000},"page":"118375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The role of Bergamot Polyphenolic Fraction (BPF) in MASLD-Induced HFpEF: Mitigate diastolic dysfunction by targeting chronic low-grade inflammation"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-5930","authenticated-orcid":false,"given":"Cristina","family":"Carresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Tavernese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Coppoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Gliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118375_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118375_bib2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118375_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111891","article-title":"Role of MASLD in CVD: a review of emerging treatment options","volume":"217","author":"Mollace","year":"2024","journal-title":"Diabetes Res. Clin. Pr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118375_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3350\/cmh.2023.0277","article-title":"Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118375_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antiox10020270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review","volume":"10","author":"Rinaldi","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2025.118375_bib6","doi-asserted-by":"crossref","first-page":"s86","DOI":"10.3350\/cmh.2022.0442","article-title":"Nonalcoholic fatty liver disease and non-liver comorbidities","volume":"29","author":"Manikat","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118375_bib7","unstructured":"Chang K.C., Su T.H., Wu C.K., Huang S.C., Tseng T.C., Hong C.M., et al. Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure. Eur J Heart Fail. \u300810.1002\/ejhf.3567\u3009."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3350\/cmh.2023.0315","article-title":"Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases","volume":"30","author":"Cheng","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118375_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118375_bib10","article-title":"Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118375_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol."},{"issue":"14","key":"10.1016\/j.biopha.2025.118375_bib13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2012.12.044","article-title":"B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction","volume":"61","author":"van Veldhuisen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118375_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/nbu.12707","article-title":"Mediterranean diet for the management of metabolic dysfunction-associated steatotic liver disease in non-Mediterranean, Western countries: what's known and what's needed?","volume":"49","author":"Sualeheen","year":"2024","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.biopha.2025.118375_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2021.06.026","article-title":"Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: an update of preclinical and clinical studies","volume":"44","author":"Bayram","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.biopha.2025.118375_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.565751","article-title":"Berberine promotes cardiac function by upregulating PINK1\/Parkin-mediated mitophagy in heart failure","volume":"11","author":"Abudureyimu","year":"2020","journal-title":"Front Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118375_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/nu12051504","article-title":"The effect of natural antioxidants in the development of metabolic syndrome: focus on bergamot polyphenolic fraction","volume":"12","author":"Carresi","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib18","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/s41598-020-59485-3","article-title":"Bergamot polyphenols improve dyslipidemia and pathophysiological features in a mouse model of non-alcoholic fatty liver disease","volume":"10","author":"Musolino","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118375_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2018.04.007","article-title":"Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kitposCD45negCD31neg cardiac stem cell activation","volume":"119","author":"Carresi","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118375_bib20","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/cells11091401","article-title":"Mitochondria bioenergetic functions and cell metabolism are modulated by the bergamot polyphenolic fraction","volume":"11","author":"Algieri","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrcardio.2017.23","article-title":"Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology","volume":"14","author":"Lopez-Crisosto","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118375_bib22","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3390\/nu13072476","article-title":"Effects of bergamot polyphenols on mitochondrial dysfunction and sarcoplasmic reticulum stress in diabetic cardiomyopathy","volume":"13","author":"Maiuolo","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ijms26030915","article-title":"Plant polyphenols as heart's best friends: from health properties, to cellular effects, to molecular mechanisms of action","volume":"26","author":"Stankovic","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41598-022-05228-5","article-title":"MAFLD progression contributes to altered thalamus metabolism and brain structure","volume":"12","author":"Nucera","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118375_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107417","article-title":"Targeting leptin\/CCL3-CCL4 axes in NAFLD\/MAFLD: a novel role for BPF in counteracting thalamic inflammation and white matter degeneration","volume":"209","author":"Cardamone","year":"2024","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function","volume":"117","author":"Zacchigna","year":"2021","journal-title":"Cardiovasc Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10741-020-10042-0","article-title":"Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg","volume":"26","author":"Miranda-Silva","year":"2021","journal-title":"Heart Fail Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","article-title":"Cardiometabolic HFpEF: NASH of the Heart","volume":"147","author":"Capone","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2025.118375_bib29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.biopha.2025.118375_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejhf.1617","article-title":"Myocardial adipose deposition and the development of heart failure with preserved ejection fraction","volume":"22","author":"Wu","year":"2020","journal-title":"Eur. J. Heart Fail"},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","article-title":"Cardiometabolic HFpEF: NASH of the Heart","volume":"147","author":"Capone","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2025.118375_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ. Heart Fail"},{"issue":"40","key":"10.1016\/j.biopha.2025.118375_bib36","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib37","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1038\/s41598-019-40393-0","article-title":"A novel echocardiographic method closely agrees with cardiac magnetic resonance in the assessment of left ventricular function in infarcted mice","volume":"9","author":"Russo","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118375_bib38","doi-asserted-by":"crossref","first-page":"H1765","DOI":"10.1152\/ajpheart.00559.2011","article-title":"New approaches in small animal echocardiography: imaging the sounds of silence","volume":"301","author":"Ram","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118375_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pcad.2020.04.011","article-title":"Heart failure with preserved ejection fraction diagnosis and treatment: an updated review of the evidence","volume":"63","author":"Del Buono","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2025.118375_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2017.10.006","article-title":"Echocardiographic evaluation of diastolic function in mouse models of heart disease","volume":"114","author":"Schnelle","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12916-022-02546-3","article-title":"Non-invasive assessment of HFpEF in mouse models: current gaps and future directions","volume":"20","author":"Villalba-Orero","year":"2022","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.biopha.2025.118375_bib42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib43","first-page":"100","article-title":"Heart failure with preserved ejection fraction - unwinding the diagnosis mystique","volume":"4","author":"Asrar Ul Haq","year":"2014","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2025.118375_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/715197","article-title":"Application of echocardiography on transgenic mice with cardiomyopathies","volume":"2012","author":"Chen","year":"2012","journal-title":"Biochem. Res. Int."},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.numecd.2022.03.003","article-title":"Lipids and diastolic dysfunction: recent evidence and findings","volume":"32","author":"Daneii","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2025.118375_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935390","article-title":"Association of metabolic dysfunction-associated fatty liver disease with left ventricular diastolic function and cardiac morphology","volume":"13","author":"Peng","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101534","article-title":"Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: a 7-year retrospective cohort study of 3,380 adults using serial echocardiography","volume":"50","author":"Kim","year":"2024","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur. J. Heart Fail"},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12947-019-0176-9","article-title":"Myocardial tissue characterisation using echocardiographic deformation imaging","volume":"17","author":"Moharram","year":"2019","journal-title":"Cardiovasc. Ultrasound"},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39499-3","article-title":"Myocardial deformation imaging by 2D speckle tracking echocardiography for assessment of diastolic dysfunction in murine cardiopathology","volume":"13","author":"Daniels","year":"2023","journal-title":"Sci. Rep."},{"issue":"1 Pt 2","key":"10.1016\/j.biopha.2025.118375_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcmg.2018.12.035","article-title":"Myocardial mechanics in patients with normal LVEF and diastolic dysfunction","volume":"13","author":"Bianco","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"18","key":"10.1016\/j.biopha.2025.118375_bib52","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/heartjnl-2019-316215","article-title":"Global longitudinal strain: clinical use and prognostic implications in contemporary practice","volume":"106","author":"Abou","year":"2020","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.biopha.2025.118375_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000630","article-title":"Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis","volume":"4","author":"Morris","year":"2017","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118375_bib55","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients","volume":"68","author":"Lee","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s11684-023-0983-0","article-title":"Berberine alleviates myocardial diastolic dysfunction by modulating Drp1-mediated mitochondrial fission and Ca2+ homeostasis in a murine model of HFpEF","volume":"17","author":"Abudureyimu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.118375_bib57","article-title":"Resveratrol ameliorates cardiac remodeling in a murine model of heart failure with preserved ejection fraction","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118375_bib58","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3945\/jn.111.157263","article-title":"Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats","volume":"142","author":"Panchal","year":"2012","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2025.118375_bib59","article-title":"The protective effect of bergamot polyphenolic fraction on reno-cardiac damage induced by DOCA-salt and unilateral renal artery ligation in rats","volume":"171","author":"Carresi","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/nu13010257","article-title":"Pathophysiological basis for nutraceutical supplementation in heart failure: a comprehensive review","volume":"13","author":"Mollace","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2025.118375_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230657","article-title":"Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis","volume":"15","author":"Mokotedi","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118375_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5603\/KP.a2018.0214","article-title":"Inflammatory markers and left ventricular diastolic dysfunction in a family-based population study","volume":"77","author":"Kloch","year":"2019","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.biopha.2025.118375_bib63","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3389\/fimmu.2020.01802","article-title":"Chemokines in non-alcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118375_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818815184","article-title":"Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease","volume":"11","author":"Chen","year":"2018","journal-title":"Ther. Adv. Gastroenterol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T01:00:16Z","timestamp":1755738016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"alternative-id":["S0753332225005694"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118375","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Bergamot Polyphenolic Fraction (BPF) in MASLD-Induced HFpEF: Mitigate diastolic dysfunction by targeting chronic low-grade inflammation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118375"}}